AHA Scientific Sessions 2020
AHA Scientific Sessions 2020
Advertisement
DocWire News EditorsAHA Scientific Sessions 2020 | December 13, 2020
Dr. Payal Kohli, a cardiologist with Cherry Creek Heart in Denver, and a DocWire News Section Advisor, talks about ...
View More
DocWire News EditorsAHA Scientific Sessions 2020 | April 6, 2023
According to new data from the American Heart Association’s COVID-19 Cardiovascular Disease Registry, Black and ...
DocWire News EditorsAHA Scientific Sessions 2020 | November 24, 2020
High-dose inactivated influenza vaccine did not reduce all-cause death or hospitalization for cardiopulmonary causes ...
DocWire News EditorsAHA Scientific Sessions 2020 | April 11, 2023
Rivaroxaban plus aspirin reduced ischemic risk of the limb, brain, and heart in peripheral artery disease (PAD) after ...
DocWire News EditorsAHA Scientific Sessions 2020 | September 6, 2023
The benefit of rivaroxaban monotherapy for patients with atrial fibrillation (AF) after coronary stenting was dependent ...
DocWire News EditorsAHA Scientific Sessions 2020 | April 11, 2023
Four out of 10 people in a middle-age population in Sweden had coronary artery disease (CAD), with one in 20 having ...
DocWire News EditorsAHA Scientific Sessions 2020 | August 30, 2023
Peripheral artery disease (PAD) was associated with continuous and linearly increasing risk for venous thromboembolism ...
DocWire News EditorsAHA Scientific Sessions 2020 | September 6, 2023
Patients in the intensive care unit (ICU) for COVID-19 had high rates of major arterial or venous thromboembolism (VTE), ...
DocWire News EditorsAHA Scientific Sessions 2020 | April 11, 2023
Rivaroxaban reduced major cardiovascular (CV) events and limb events in patients with peripheral artery disease (PAD) ...
DocWire News EditorsAHA Scientific Sessions 2020 | November 16, 2020
The administration of omega-3 carboxylic acid (CA) at a high dose did not reduce the incidence of major adverse ...
DocWire News EditorsAHA Scientific Sessions 2020 | July 10, 2023
A shorter one-month duration of treatment with dual-antiplatelet therapy (DAPT) followed by aspirin monotherapy was as ...
DocWire News EditorsAHA Scientific Sessions 2020 | April 23, 2023
Patients with chronic kidney disease (CKD) and non-valvular atrial fibrillation (NVAF) were more likely to use vitamin K ...
DocWire News EditorsAHA Scientific Sessions 2020 | November 16, 2020
Rivaroxaban was comparable to warfarin in patients with atrial fibrillation (AF) with bioprosthetic mitral valves, ...
DocWire News EditorsAHA Scientific Sessions 2020 | November 13, 2020
Daily supplementation with omega-3 fatty acids and/or vitamin D3 did not increase or decrease the risk of developing ...
DocWire News EditorsAHA Scientific Sessions 2020 | November 13, 2020
The combined use of a polypill plus aspirin in an intermediate-risk population of people without cardiovascular disease ...
DocWire News EditorsAHA Scientific Sessions 2020 | April 10, 2023
In patients with heart failure with reduced ejection fraction (HFrEF), omecamtiv mecarbil significantly reduced the risk ...
DocWire News EditorsAHA Scientific Sessions 2020 | April 23, 2023
Expert adjudication of electronic medical records (EMRs) revealed that oral anticoagulants are not as underused in ...
Advertisement
Advertisement
Advertisement
Latest News

May 7, 2024